Neurofilament light as a biomarker of axonal degeneration in patients with mild cognitive impairment and Alzheimer’s disease

Neurofilament light as a biomarker of axonal degeneration in patients with mild cognitive impairment and Alzheimer’s disease

Cerebrospinal fluid neurofilament light and plasma neurofilament light concentrations are elevated in patients with mild cognitive impairment and Alzheimer’s disease. We investigated the clinical relevance of increased neurofilament light concentrations in mild cognitive impairment and Alzheimer...

Full description

Bibliographic Details
Main Authors:	Yi Chen, Joseph Therriault, Jing Luo, Maowen Ba, Hua Zhang, Alzheimer’s Disease Neuroimaging Initiative
Format:	Article
Language:	English
Published:	IMR Press 2021-12-01
Series:	Journal of Integrative Neuroscience
Subjects:	neurofilament light alzheimer's disease mild cognitive impairment cerebrospinal fluid
Online Access:	https://www.imrpress.com/journal/JIN/20/4/10.31083/j.jin2004088

Similar Items

Cerebrospinal fluid and plasma neurofilament light relate to abnormal cognition
by: Katie E. Osborn, et al.
Published: (2019-12-01)

Apolipoprotein E ε4 and ε3 alleles associate with cerebrospinal fluid tau and cognition in the presence of amyloid-𝜷 in mild cognitive impairment but not in Alzheimer’s disease
by: Feng Xing, et al.
Published: (2021-06-01)

Neurofilament Light Chain as a Potential Biomarker in Plasma for Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review and a Meta-Analysis
by: Zhenyi Fan, et al.
Published: (2023-06-01)

NeuropsychBrainAge: A biomarker for conversion from mild cognitive impairment to Alzheimer's disease
by: Jorge Garcia Condado, et al.
Published: (2023-10-01)

Dual-Model Radiomic Biomarkers Predict Development of Mild Cognitive Impairment Progression to Alzheimer’s Disease
by: Hucheng Zhou, et al.
Published: (2019-01-01)

Associations between Neuropsychiatric Symptoms and Alzheimer’s Disease Biomarkers in People with Mild Cognitive Impairment
by: Giulia Arenare, et al.
Published: (2023-08-01)

Alzheimer's disease: 3‐Dimensional MRI texture for prediction of conversion from mild cognitive impairment
by: Collin C. Luk, et al.
Published: (2018-01-01)

Development of quantitative and continuous measure for severity degree of Alzheimer’s disease evaluated from MRI images of 761 human brains
by: Sangyeol Kim, et al.
Published: (2022-08-01)

The personalized Alzheimer's disease cortical thickness index predicts likely pathology and clinical progression in mild cognitive impairment
by: Annie M. Racine, et al.
Published: (2018-01-01)

Brain network construction and analysis for patients with mild cognitive impairment and Alzheimer's disease based on a highly‐available nodes approach
by: Xiaopan Zhang, et al.
Published: (2021-03-01)

The Relationship Between Hippocampal Volumes and Delayed Recall Is Modified by APOE ε4 in Mild Cognitive Impairment
by: Xiwu Wang, et al.
Published: (2019-02-01)

Erlangen Score as a tool to predict progression from mild cognitive impairment to dementia in Alzheimer’s disease
by: Inês Baldeiras, et al.
Published: (2019-01-01)

Polygenic effects on the risk of Alzheimer’s disease in the Japanese population
by: Masataka Kikuchi, et al.
Published: (2024-02-01)

Brain Connectivity Based Prediction of Alzheimer’s Disease in Patients With Mild Cognitive Impairment Based on Multi-Modal Images
by: Weihao Zheng, et al.
Published: (2019-11-01)

Early diagnosis of Alzheimer’s disease using machine learning: a multi-diagnostic, generalizable approach
by: Vasco Sá Diogo, et al.
Published: (2022-08-01)

Specific White Matter Tracts and Diffusion Properties Predict Conversion From Mild Cognitive Impairment to Alzheimer’s Disease
by: David B. Stone, et al.
Published: (2021-07-01)

Neuropsychological predictors of conversion from mild cognitive impairment to Alzheimer’s disease: a feature selection ensemble combining stability and predictability
by: Telma Pereira, et al.
Published: (2018-12-01)

Plasma adiponectin levels predict cognitive decline and cortical thinning in mild cognitive impairment with beta-amyloid pathology
by: Keun You Kim, et al.
Published: (2022-11-01)

Hearing Loss in Alzheimer’s Disease Is Associated with Altered Serum Lipidomic Biomarker Profiles
by: Daniel A. Llano, et al.
Published: (2020-11-01)

Uncovering heterogeneous cognitive trajectories in mild cognitive impairment: a data-driven approach
by: Xiwu Wang, et al.
Published: (2023-03-01)

Atrophy of hippocampal subfields relates to memory decline during the pathological progression of Alzheimer’s disease
by: Yaqiong Xiao, et al.
Published: (2023-12-01)

MRI Asymmetry Index of Hippocampal Subfields Increases Through the Continuum From the Mild Cognitive Impairment to the Alzheimer's Disease
by: Alessia Sarica, et al.
Published: (2018-08-01)

Cerebrospinal Fluid Biomarkers for the Diagnosis of Prodromal Alzheimer’s Disease in Amnestic Mild Cognitive Impairment
by: Jung Eun Park, et al.
Published: (2019-03-01)

Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairment
by: Pia Kivisäkk, et al.
Published: (2023-03-01)

Single‐nucleotide polymorphisms are associated with cognitive decline at Alzheimer's disease conversion within mild cognitive impairment patients
by: Eunjee Lee, et al.
Published: (2017-01-01)

A selenium species in cerebrospinal fluid predicts conversion to Alzheimer’s dementia in persons with mild cognitive impairment
by: Marco Vinceti, et al.
Published: (2017-12-01)

Detection of Alzheimer's disease at mild cognitive impairment and disease progression using autoantibodies as blood‐based biomarkers
by: Cassandra A. DeMarshall, et al.
Published: (2016-01-01)

Classification of Alzheimer's Disease, Mild Cognitive Impairment, and Cognitively Unimpaired Individuals Using Multi-feature Kernel Discriminant Dictionary Learning
by: Qing Li, et al.
Published: (2018-01-01)

Longitudinal associations of apathy and regional tau in mild cognitive impairment and dementia: Findings from the Alzheimer's Disease Neuroimaging Initiative
by: Pranitha Y. Premnath, et al.
Published: (2024-01-01)

Identification of Alzheimer’s Disease on the Basis of a Voxel-Wise Approach
by: Iman Beheshti, et al.
Published: (2019-07-01)

Posterior atrophy predicts time to dementia in patients with amyloid-positive mild cognitive impairment
by: Jung-Min Pyun, et al.
Published: (2017-12-01)

Investigation on the Alteration of Brain Functional Network and Its Role in the Identification of Mild Cognitive Impairment
by: Lulu Zhang, et al.
Published: (2020-09-01)

Aerobic exercise does not affect serum neurofilament light in patients with mild Alzheimer’s disease
by: Kristian Steen Frederiksen, et al.
Published: (2023-01-01)

Predictability of polygenic risk score for progression to dementia and its interaction with APOE ε4 in mild cognitive impairment
by: Jung-Min Pyun, et al.
Published: (2021-08-01)

Prescribing cholinesterase inhibitors in mild cognitive impairment—Observations from the Alzheimer's Disease Neuroimaging Initiative
by: Eddie Stage, et al.
Published: (2021-01-01)

Exploratory Assessment of Proteomic Network Changes in Cerebrospinal Fluid of Mild Cognitive Impairment Patients: A Pilot Study
by: Aida Kamalian, et al.
Published: (2023-07-01)

Association Between Serum Neurofilament Light Chain and Cognitive Performance Among Older Adults in the United States: A Cross-Sectional Study
by: Yuanyuan Gao, et al.
Published: (2023-10-01)

Convolutional Neural Networks-Based MRI Image Analysis for the Alzheimer’s Disease Prediction From Mild Cognitive Impairment
by: Weiming Lin, et al.
Published: (2018-11-01)

FDG-PET hypermetabolism is associated with higher tau-PET in mild cognitive impairment at low amyloid-PET levels
by: Anna Rubinski, et al.
Published: (2020-10-01)

A Systematic Review and Meta-Analysis of Cerebrospinal Fluid Amyloid and Tau Levels Identifies Mild Cognitive Impairment Patients Progressing to Alzheimer’s Disease
by: Yunxing Ma, et al.
Published: (2022-07-01)